Evidence map›Paper›PMID 38471832›Full record

ArticleJournal of the American Heart Association2024

Prognostic Utility of Society for Cardiovascular Angiography and Interventions Shock Stage Approach for Classifying Cardiogenic Shock Severity in Takotsubo Syndrome.

Andrea Camblor-Blasco, Ivan J Nuñez-Gil, Albert Duran Cambra, Manuel Almendro-Delia, Eduard Ródenas-Alesina, Clara Fernández-Cordon, Oscar Vedia, Miguel Corbí-Pascual, Emilia Blanco-Ponce, Sergio Raposeiras-Roubin and 10 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Journal of the American Heart Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 16 institutions in 1 country.

Andrea Camblor-BlascoCardiology Department Hospital Universitari Vall d'Hebron Barcelona Spain.
Ivan J Nuñez-GilInstituto Cardiovascular, Hospital Clínico San Carlos, Universidad Complutense Madrid Spain.ORCID 0000-0002-1779-3102
Albert Duran CambraCardiology Department Hospital de Sant Pau Barcelona Spain.ORCID 0000-0002-5692-6844
Manuel Almendro-DeliaCardiology Department Hospital Universitario Virgen Macarena Sevilla Spain.ORCID 0000-0001-7144-4782
Eduard Ródenas-AlesinaCardiology Department Hospital Universitari Vall d'Hebron Barcelona Spain.ORCID 0000-0003-1638-7820
Clara Fernández-CordonCardiology Department Hospital General Universitario Gregorio Marañón Madrid Spain.ORCID 0000-0002-2492-2873
Oscar VediaInstituto Cardiovascular, Hospital Clínico San Carlos, Universidad Complutense Madrid Spain.ORCID 0000-0001-5062-3335
Miguel Corbí-PascualCardiology Department Complejo Hospitalario de Albacete Albacete Spain.ORCID 0000-0001-5923-1290
Emilia Blanco-PonceCardiology Department Hospital Universitario Arnau de Vilanova Lérida Spain.ORCID 0000-0001-6157-679X
Sergio Raposeiras-RoubinCardiology Department Hospital Álvaro Cunqueiro Vigo, Pontevedra Spain.ORCID 0000-0002-6462-4715
Marta Guillén MarzoCardiology Department Hospital Joan XXIII Tarragona Spain.ORCID 0000-0003-3345-2356
Alejandro Sanchez Grande FlechaCardiology Department Hospital Universitario de Canarias La Laguna Spain.ORCID 0009-0008-0438-5194
Jose Maria Garcia AcuñaCardiology Department Hospital Clinico Universitario de Santiago de Compostela Santiago de Compostela Spain.ORCID 0000-0003-1406-4171
Jorge SalamancaCardiology Department Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP) Madrid Spain.ORCID 0000-0002-5067-5052
Juan M Escudier-VillaCardiology Department Hospital Puerta de Hierro Majadahonda Spain.ORCID 0000-0003-3603-8433
Agustin C Martin-GarciaCardiology Department Complejo Asistencial Universitario de Salamanca Salamanca Spain.ORCID 0000-0001-8662-3791
Marco TomasinoCardiology Department Hospital Universitari Vall d'Hebron Barcelona Spain.ORCID 0000-0003-1989-4342
Ravi VaziraniInstituto Cardiovascular, Hospital Clínico San Carlos, Universidad Complutense Madrid Spain.ORCID 0000-0002-7337-0593
Alberto Perez-CastellanosServicio de Cardiología, Instituto de Investigación Sanitaria Islas Baleares (IdISBa) Hospital Universitario Son Espases Palma Spain.ORCID 0000-0002-5879-0012
Aitor UribarriCardiology Department Hospital Universitari Vall d'Hebron Barcelona Spain.ORCID 0000-0002-6911-7480
Hospital Clínico San Carlos · ESCentro de Investigación en Red en Enfermedades Cardiovasculares · ESVall d'Hebron Hospital Universitari · ESComplejo Hospitalario de Salamanca · ESComplejo Hospitalario Universitario de Albacete · ESComplejo Hospitalario Universitario de Santiago · ESHealth Research Institute of the Balearic Islands · ESHospital de Sant Pau · ESHospital General Universitario Gregorio Marañón · ESHospital Universitari Arnau de Vilanova · ESHospital Universitari Joan XXIII de Tarragona · ESHospital Universitario de Canarias · ESHospital Universitario de La Princesa · ESHospital Universitario Puerta de Hierro Majadahonda · ESHospital Universitario Virgen Macarena · ESUniversity Hospital Complex Of Vigo · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiogenic shock (CS) is a significant complication of Takotsubo syndrome (TTS), contributing to heightened mortality and morbidity. Despite this, the Society for Cardiovascular Angiography and Interventions (SCAI) staging system for CS severity lacks validation in patients with TTS and CS. This study aimed to characterize a patient cohort with TTS using the SCAI staging system and assess its utility in cases of TTS complicated by CS. METHODS AND

resultsFrom a TTS national registry, 1591 consecutive patients were initially enrolled and stratified into 5 SCAI stages (A through E). Primary outcome was all-cause in-hospital mortality; secondary end points were TTS-related in-hospital complications and 1-year all-cause mortality. After exclusions, the final cohort comprised 1163 patients, mean age 71.0±11.8 years, and 87% were female. Patients were categorized across SCAI shock stages as follows: A 72.1%, B 12.2%, C 11.2%, D 2.7%, and E 1.8%. Significant variations in baseline demographics, comorbidities, clinical presentations, and in-hospital courses were observed across SCAI shock stages. After multivariable adjustment, each higher SCAI shock stage showed a significant association with increased in-hospital mortality (adjusted odds ratio: 1.77-29.31) compared with SCAI shock stage A. Higher SCAI shock stages were also associated with increased 1-year mortality.

conclusionsIn a large multicenter patient cohort with TTS, the functional SCAI shock stage classification effectively stratified mortality risk, revealing a continuum of escalating shock severity with higher stages correlating with increased in-hospital mortality. This study highlights the applicability and prognostic value of the SCAI staging system in TTS-related CS.

Indexed as

Shock, CardiogenicTakotsubo CardiomyopathyAgedAged, 80 and overAngiographyFemaleHospital MortalityHumansMaleMiddle AgedMorbidityPrognosiscardiogenic shockextracorporeal membrane oxygenationheart failureSCAITakotsubo syndrome

Identifiers

PMID38471832
PMCPMC11010033
OpenAlexW4392780013

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.